Personalized blood tests on patients with cancer can tell whether treatment is working, or whether disease has returned. A sample of the tumor is used to identify the unique cancer gene sequence, meaning the blood test identifies tumor “rearrangements” of the DNA. This method of “fingerprinting” the cancer can reportedly track the development of the cancer in the specific individual’s body. Read More…
